Skip to main content


Fig. 6 | Alzheimer's Research & Therapy

Fig. 6

From: FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease

Fig. 6

Change in cognition (Alzheimer‘s Disease Assessment Scale 11-item cognitive assessment [ADAS-Cog11], Controlled Oral Word Association Test [COWAT]) over 96 weeks, displayed as correlation with the immunoglobulin G (IgG) titre AUC. Results are shown for completers (left) and for patients with a positive biomarker profile (right). Results are shown with raw AUC values (ad) and with AUC values corrected for disease severity (eh). Category Fluency Test results were inconclusive (not shown)

Back to article page